Oncopeptides AB

03/23/2026 | Press release | Distributed by Public on 03/23/2026 04:34

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

Oncopeptides' CEO Sofia Heigis recently presented the company at the Redeye event Commercialization in Life Science. The presentation was followed by a Q&A.

Watch the presentation here or click on the video below (the presentation is in Swedish).

Oncopeptides AB published this content on March 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 23, 2026 at 10:34 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]